In addition to holding 155 positions, its top 10 holdings make up just 14. View the latest ETF prices and news for better ETF investing. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. 2% weight, and there are 133 holdings in total in the fund (Figure 1). The sale of ETFs is subject to an activity assessment fee (from $0. Performance and Risk. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. 70% so far this year and is down about -16. While IBB has many more holdings than XBI (376 vs. 27%. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. Region Percentage; North, Central and South America: 99. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. Snapshot: XBI. 36% of total assets under management. Export data to Excel for your own analysis. Analysis of these related ETFs and how they are trading may provide insight to this commodity. 08 per unit, that means that analysts see 59. 58% and is down about -14. XBI. Last Price Today's Change Today's Volume : Prospectus. IBB has 8. XBI is suitable for investors seeking to. 37% in the last one. But that definitely wasn't the case recently. Learn everything about SPDR S&P Biotech ETF (XBI). 74. The fund’s NAV was $81. Advertisement. Themes & Subsectors ETFs. Overview. The stock holdings of the XBI tends to be re. 47% vs -5. 2% Top Ten Holdings. So far this year, XBI has lost about -5. 87. N/A. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 50 down to $98. Price Chart. XBI has a beta of 1. 49% weight in the XBI, are bumping into the $164 head resistance and are. 01M), Whalerock Point Partners LLC ($343. Mettler-Toledo International Inc. 94 per share, with $121. 20. The Health category average is 45. 35% vs 0. $5. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Top 10 Holdings 16. 12 and $91. Currency in USD Follow 2W 10W 9M 72. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. Free ratings, analyses, holdings, benchmarks, quotes, and news. XLY News. Its top 10 holdings account for approximately 16. 01%). Sector ETFs. 96%, and is down about -5. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. 07. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. In XBI, the top five holdings together represent only 9. 06 as the 52 week high point — that compares with a last trade of $109. Below is the comparison between BBH and XBI. Asset type. XBI has an overall POWR Rating of D, equating to a Sell. SPDR S&P Biotech ETF is a equity fund issued by SSgA. 73% so far this year and is down about -39. More XBI Holdings Current Portfolio Date Nov 16, 2023; Equity Holdings 132; Bond Holdings 0;During the previous two years, 872 institutional investors and hedge funds held shares of SPDR S&P Biotech ETF. $36. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. Fund Analysis. Holdings. BIIB is also in the top 15 XBI holdings. 67. Visitors trend 2W 10W 9M. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. XBI vs ARKG. VHT has a. Diversification. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. 22%: Revolution. Plus view geographic exposure, currency. 12% in the. ( AMGN) = 9. Per cent of portfolio in top 5 holdings: 8. Performance and Risk. High volatility: Small and mid-cap biotech stocks typically exhibit greater price fluctuations, exposing investors to higher levels of market risk and. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. The top 10 holdings account for about 11. XBI's top 10 holdings account for about 11. 1. 13%) Gold 1,980. 1% which highlights the scope of the fund and diversification away from company-specific risks. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security. 46% YTD Daily Total Return ETF Summary. 97. 08 per unit, that means that analysts see 59. XBI has a lower 5-year return than XLV (-5. 2 %. 26% rating in the component of Value. 78% of XBI's total assets under management. Holdings. 70% so far this year and is down about -16. Top 10 Holdings. According to 9 analysts, the average rating for IMGN stock is "Strong Buy. BTEK11. ETF Channel Staff - Friday, October 20, 6:48 AM. 04 per unit, that means that analysts see 73. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. The ETF has lost about -12. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. XBI. 27%: Number of Holdings 29: Price/Book Ratio Price/Book Ratio. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. 5% year-to-date and 38. Dividend Yield. Trades. VHT has a higher 5-year return than XBI (7. The weighted harmonic average of closing market price divided by. Oct 10, 2022 01:14PM EDT. . For an ETF, this widget displays the top 10 constituents that make up the fund. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 58%: Halozyme Therapeutics Inc:XLY News. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. NAV as of Nov 16, 2023. Neena Mishra May 10, 2023. 80% of total assets under management. Share class size. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. Both FBT and XBI are ETFs. View and export this data back to 2006. The vast majority of XBI holdings have less. NEW: Experience our best charts yet. 0 reviews. IBB vs. Holdings; Holdings Overlap; Attribution; Fundamental Chart; Scatter Plot; Tech Chart; Stress Test; ESG; Data; More. S. 06 as the 52 week high point — that compares with a last trade of $102. 2013. 97. 2. There is no guarantee the funds will achieve their stated investment objectives. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. S. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 67% Symbol Company Name Industry Percent of Assets MRTX Mirati Therapeutics Inc Biotechnology 2. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). 4; Top 10 Holdings % Portfolio Weight Market Value USD 2014. XBI has lost 27. 80% of total assets under management. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. 94 as the 52 week high point — that compares with a last trade of $116. 35%). 60 as the 52 week high point — that compares with a last trade of $77. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Toggle navigationNovavax Inc. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. 97. Veeva Systems. Its fund flows were negative $259. , respectively. 95% for the trailing three-year period, which makes the fund a high risk choice in the space. XBI focuses on health care investments and follows the S&P Biotech Index. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 66 +2. Additionally. Better trading starts here. Looking at the chart above, XBI's low point in its 52 week range is $100. The table below compares many ETF metrics between IBB and XBI. 57 billion. 86% so far this year and is down about -32. Feel free to the browse the list and view the comparisons that are of an interest to you. FA Report PDF. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Staples:. 39M), JPMorgan Chase & Co. 75. Summary. Check out the side-by-side comparison table of IBB vs. Company Change % Net. Skip to main content. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 06 as the 52 week high point — that compares with a last trade of $102. February 15, 2023 — 10:47 am EST. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. by Morningstar Manager Research. Quote. VEEV. Holdings. The ETF return is roughly 4. 84% for the trailing three-year period, which makes the fund a high risk choice in the space. Summary From a population of some 350 actively-traded, substantial, and growing ETFs this is a currently attractive addition to a portfolio whose principal objective is wealth accumulation by active investing. TipRanks | Stock Market Research, News and Analyst Forecasts. Performance and Risk. 2401 Millstream Rd 125 Victoria BC. The firm has a market cap of $5. 79 as the 52 week high point — that compares with a last trade of $133. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 17% for the trailing three-year period, which makes XBI a high. 35%. XBI holdings. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. Also I like this style of etf from power shares because the holdings are less weighted in the top two powerhouses (Amgen and Gilead for PJP) than "traditional" ETF's. Its holdings reflect the movement of like 750b worth of companies. 64 per share, with $174. 44 per share, with $92. 06 as the 52 week high point — that compares with a last trade of $112. Both BBH and XBI are ETFs. 80 per share, with $92. 60 as the 52 week high point — that compares with a last trade of $69. 15 billion assets under management. The weighted harmonic average of closing market price divided by. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 39. View the XBI funds market news. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 1. Up vote for PJP but it is pharmaceutical focused and technically not as broad as other biotech ETF's, though the top 10 holdings are comparable. 95. Performance and Risk. com) ReturnsXBI's top 10 holdings account for about 10. 26 during this last 52-week period. 42 billion worth of. Monday's ETF Movers: XBI, QCLN. 19%. 250-391-1110. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. 3% over the same period: Image Source: Zacks Investment Research. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. Search tickers or categories. The 10 largest holdings have a combined 17. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. Holdings AS OF 04/30/2023. Again, top 10 holdings. 10(-0. With XBI trading at a recent price near $122. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. US. S. Meanwhile, XBI equal weights its holdings. Total healthcare and life sciences M&A was about $71. Holdings; Performance; Risk; Advertisement. 46M), Matrix Capital Management Company LP ($188. Looking at the chart above, XBI's low point in its 52 week range is $62. Net expense ratio. 64 billion, a PE ratio of 11. Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. 35%). XBI holdings. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Fidelity does not endorse or adopt their content. XBI has traded between $62. Netherlands. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. argenx SE ADR. Dividend Yield. 97. N/A. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. XBI has lost 27. 50. 16bn USD. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. Real Estate ETFs. 94 per share, with $121. XBI Holdings (Seeking Alpha) Risks. 50(-0. Free ratings, analyses, holdings, benchmarks, quotes, and news. 2015. 94 per share, with $116. Both XBI and XLV are ETFs. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. The fund's investments total to approximately $6. Below is the comparison between XBI and XLV. 35%. 08%. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. XBI has traded between. 4% of the stocks in our database. With XBI trading at a recent price near $131. 2 %. $0. 00. Themes & Subsectors ETFs. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. IBB has a higher 5-year return than XBI (0. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. Both ARKG and XBI are ETFs. 83%: Other: 0. The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. LABU. XBI has a Diversified Portfolio. ARGX. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. 78% so far this year and in the past one year (as of 11/20/2023), respectively. 60 as the 52 week high point — that compares with a last trade of $69. The main reason for this is the additional risk mitigation an ETF provides given its myriad holdings within a sector. 58. Sector Exposure and Top Holdings. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. VHT has a lower expense ratio than XBI (0. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Performance and Risk The ETF has lost about -9. 45% and is down about -9. $6. 31 per share, with $92. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. Complete SPDR S&P Biotech ETF funds overview by Barron's. 7% of assets. Looking at the chart above, XBI's low point in its 52 week range is $62. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). SPDR® S&P Biotech ETF. SPDR S&P BIOTECH ETF 87. Holdings. Wix. 01%). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. It's trading down (17%) versus LABU, down (68%) in one-year performance. 11. Cash and Equivalents. 1% vs 0. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. Market On Millstream The. Site search Search. XLV. With XBI trading at a recent price near $131. 07. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5.